key: cord-0968462-doma9340
authors: Wang, Panpan; Tian, Deqiao
title: Bibliometric Analysis of Global Scientific Research on COVID-19
date: 2021-01-23
journal: J Biosaf Biosecur
DOI: 10.1016/j.jobb.2020.12.002
sha: b640a54f8625c3911295b134d527d45d7441b883
doc_id: 968462
cord_uid: doma9340

Since the outbreak of coronavirus disease 2019 (COVID-19), a large number of COVID-19-related reports have been published in journals or submitted to preprint platforms. In this study, we search the COVID-19-related literature officially published and included in the Web of Science (WOS) database or submitted to four preprint platforms: bioRxiv, medRxiv, Preprints, and SSRN. Using data on the number of reports, author institution, country, and research category, we analyze global trends in COVID-19 research, including institution distribution and research hotspots. The results show that a large number of COVID-19-related reports have been produced; the United States has contributed the most published literature, followed by China. The United States has also published the most reports included in the WOS in the categories of non-pharmaceutical interventions, treatment, and vaccine-related reports, while China has published the most literature in the categories of clinical features and complications, virology and immunology, epidemiology, and detection and diagnosis. Publication countries are concentrated in Asia, North America, and Europe, while South America and Africa have less literature. In conclusion, many scientific research issues related to COVID-19 need to be further clarified and COVID-19 research urgently needs global cooperation.

Since Eearly in the 21st century, humans have suffered SARS (severe acute respiratorySevere Acute Respiratory syndromeSyndrome (SARS) and MERS (Middle East respiratoryRespiratory syndromeSyndrome (MERS), two epidemics caused by members of the coronavirus group. After each outbreak, a large number of related studies havehad beenwere carried out by countries that are greatly affected by the epidemic and some strong research as well as countriesthose with a strong research tradition such as the United States. [1] At the end of December 2019, a new coronavirus disease broke out and spread rapidly around the worldglobally. [2, 3] On March 11, 2020, the World Health Organization announced that COVID-19 had caused become a global "pandemic". [4] The Commented [A1]: Dear Author, Thanks for providing this opportunity to assist you with this manuscript. I have edited the text for language, grammar, and improved clarity. I have also ensured that the style used predominantly by you is consistently maintained throughout the manuscript.

My best wishes for your success with the manuscript.

We acknowledge your contribution to We also understand how difficult it must be to keep abreast with the latest developments, given the surge in COVID-19 research output across disciplines. Now, more than ever, collaboration is of the essence and to help researchers connect and collaborate, we have launched covid19.researcher.life -an AI-powered, expert-curated site that offers access to the latest research and information on COVID-19 and allows researchers across disciplines to collaborate. This platform also provides access to evidence-based answers to questions around COVID- 19 and allows interested members of the public to suggest answers to problems that researchers and practitioners are struggling with. We invite you to be a part of this initiative against COVID-19. Bookmark covid19.researcher.life and start contributing today! outbreak of the COVID-19 pandemicepidemic poseshas posed a huge challenge to global public health and has a profound impact on the economic and social operations of countries. [5] CurrentlyI, the COVID-19 epidemict has caused more than 44 million infections in 218 countries worldwide, and more than 1,110,000 people have been killed. [6] Since the outbreak of the COVID-19 pandemic, researchers around the worldglobally have carried out relevant research from many aspects such as virology and immunology, disease transmission and clinical processesprocess, disease diagnosis and management, experimental therapy, and vaccine development. [7] [8] [9] Bibliometric analysis is an objective evaluation of the scientific research situation, which can quantitatively present the research hotspots, development trends, and key research institutions of relevant scientific research activities;, and clarify research ideas for scientific researchers;, and provide a reference for scientific research cooperation. [10] 

According to the search results, statistical analysis wasis performed in terms of the number of reports, author institution, country, and research category.

The author's institution and country are were selected as the institution and country information from of the first author (where the first author hads multiple institutions, we selected the first In order Toto further understand the current hotspotshot spots and trends of COVID-19 research, we referred to the classification from the WHO database of COVID-19 literature [11] and divided all the 

As of OctoberOct 15, 2020, the WOS database includedincludes a total of 12,021 reports related to COVID-19. FAs for preprints, 2040 reports hadve been submitted to the bioRxiv platform, the first of which was submitted by Xiamen University on January 19, 2020; [12] 7555 reports hadve been submitted to the medRxiv platform, the first of which was submitted by Lancaster University on January 23, 2020; [13] ; 1046 reports hadve been submitted to the Preprints platform, the first of which was submitted by Shenzhen University on January 30, 2020; [14] ; and 2028 reports hadve been submitted to the SSRN platform, the first of which was submitted by Boston Children's Hospital on January 24, 2020. [15] In the first five5 months (2020-012020-01 through 2020-05January to May 20202020-05), the total number of papersamount of literature submitted to the four preprint platforms monthly is more than the number of reports included in the by WOS; starting from JuneJun 2020, the number of papers amount of literature included in theby WOS monthly continues to exceed the amount number submitted to the four preprint platforms. Currently, the growth rate of reports included in the WOS or submitted to these the preprint platforms tends to beis flat ( Fig. 1 

According to the first author information of the relevant literature, more than 5000 institutions in 173 The country that has published the most reports included by in the WOS monthly within the first six6 months (2020-012020-01 through 2020-062020-06)of 2020 is China. Since July 2020, the U.S. The 12,021 reports included in the WOS werehave been published in 2076 journals. As shown in Table   3 , (Table 5) . research effort and played an important role in the epidemic response. [16, 17] . many reports in a short period. [18] . So far, COVID-19-related research has involved non-pharmaceutical interventions, epidemiology, clinical characteristics, treatment, detection and diagnosis, and virology and immunology, disease transmission, vaccines, and other categories.;

Additionallybesides, there are some psychological studiesliterature related to science were published, thatwhich werehave examined mainly devoted to studying the psychological status of the public and medical staff during the epidemic. [19] . In terms of the total number of articles, the leading categories 

In terms of monthly publications, much of the literature has been submitted to the preprint platform in the previous period. Within five5 months of the publication of the first report, the total number of reports submitted to the four preprint platforms each month was greater than the literature included by in the WOS. In terms of the total number of articles, aEvens of now, the number of reports submitted to the four preprint platforms continues to exceeds the reports included in the WOS. In response to the Ebola and Zika outbreaks, the proportion of submitted fewer than 5% of articles were submitted to the preprint platforms. of the total number was less than 5% [20] . In recent years, the preprint platforms have attracted increasingmore and more attention from researchers because of their fast and free open-source release. Since the establishment of the first physics preprint platform arXiv in 1991, there have been dozens of preprint platforms involved in various fields, including the medRxiv and bioRxiv platforms in the biomedical field and, the Chemrxiv platform in the chemical field. In 2017, Science ranked the preprint platform among the top 10 scientific and technological advances inof thate year. As it matures, the preprint platform is considered to have great potential in for accelerating the spread of scientific discoveries, disseminating information in emergencies, and supporting infectious disease outbreak response; [20, 21] ; the preprint platform is also considered to be helpful for scientific and technological exchanges. [22] . However, recent studies have pointed out that in the COVID-19 epidemic response, the preprint platform has played an important role while also revealing its weaknesses,: the articles submitted to preprint platforms have not been peer-reviewed by experts,, and the paper quality of the article is worrying. [23] . For example, a paper from by the an Indian research team submitted to bioRxiv in February suggested that the new coronavirus may contain HIV inserts, and many people speculated that the new coronavirus may be a product of artificial modification based on it. The research team subsequently admitted that the research data were incorrect and retracted theat article.

Therefore, the prospects for preprints and how to effectively use preprint literature in scientific research and emergency response to infectious diseases are matters worth discussing. Many related scientific research issues such as the natural origin, capacity, and means of transmission;, the vaccine for COVID-19;, and effective treatment of COVID-19 remain unclear. [9] . Also, Therethere are also large differences in economic and social conditions, medical resource reserves, and the ability to respond to public health security incidents in various countries. [24, 25] . There are great variables in whereThe direction in which the COVID-19 epidemic will eventually go is unknown. Kissler et al.

believedbelievestate that the epidemic maycan not end in one1 to or two2 years. Without effective treatment and vaccines, athe strategy based on close contact tracking and effective isolation can reduce the incidence of SARS-COV-2, but the long-term development of the epidemic would havepose a huge impact on the medical systems of various countries and the economies of various countries. [26] . To a certain extent, the publication of literature represents the corresponding scientific and technological level and reflects the global regional biomedical technology gap at the global and regional scale. As for the total number of reports, tThe United StatesU.S., China, Italy, and the United KingdomUKU.K.

contribute nearly 60% of the reports included by in the WOS and nearly 80% of the reportsthose published in the top journals. There is relatively more literature from Asia, Europe, and North America, and fewless studiesliterature than from Africa and, South America, and other regions. Therefore, in the context of global interconnection, there is an urgent need for the cooperation of governments and scientific researchers from all over the worldglobally to jointly fight the epidemic.

With continuous changes in the epidemic situation in various countries in the world, such as the expected release of more vaccine-related research results, the trend of literature data growth and the research priorities of various countries may change. A limitation is that the source of the literature data for this research may not cover local journals published in languages other than English in various countries, even though they have played an important role in the local outbreak response.

The authors declare that they have no conflict of interest.

MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? -A bibliometric analysis

A novel coronavirus outbreak of global health concern

A Novel Coronavirus from Patients with Pneumonia in China

Director-General's opening remarks at the media briefing on COVID-19 -11

The socio-economic implications of the coronavirus pandemic (COVID-19): A review

COVID-19) outbreak situation 2020

Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review

SnapShot: COVID-19

Characteristics of SARS-CoV-2 and COVID-19

Bibliometric indicators: quality measurements of scientific publication

COVID-19 Global literature on coronavirus disease

A mathematical model for simulating the transmission of Wuhan novel Coronavirus

Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions

Novel coronavirus: where we are and what we know

Early Transmissibility Assessment of a Novel Coronavirus in Wuhan

From China: hope and lessons for COVID-19 control

Timely research papers about COVID-19 in China

China coronavirus: how many papers have been published?

Mental Health and the Covid-19 Pandemic

Preprints: An underutilized mechanism to accelerate outbreak science

Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility

Preprints are good for science and good for the public

How swamped preprint servers are blocking bad coronavirus research

An appeal for practical social justice in the COVID-19 global response in low-income and middle-income countries

Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

The authors declare no conflict of interest.